| HGNC Family | G protein-coupled receptors |
| Name | olfactory receptor, family 4, subfamily K, member 14 |
| Description | Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nA careful review of the provided abstracts (e.g."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "reveals that none of these studies mention or characterize OR4K14. Instead, the collective literature is devoted to deciphering the role of intermedin (also called adrenomedullin2) – a novel member of the calcitonin/calcitonin gene‐related peptide family. These articles focus on its receptor interactions (via complexes of the calcitonin receptor–like receptor [CRLR] with receptor activity–modifying proteins [RAMPs]) and its involvement in diverse processes ranging from vascular homeostasis and endothelial barrier regulation to metabolic modulation and cardioprotection.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSeveral studies report that intermedin acts as a nonselective agonist for CRLR/RAMP complexes and exerts protective effects in conditions such as hypertension, atherosclerosis, myocardial ischemia/reperfusion injury, and sepsis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": " Its signaling, which can involve cAMP/PKA, p38 MAPK, and other cascades, helps to repair disrupted endothelial junctions, reduce inflammatory cell infiltration, decrease foam-cell formation via modulation of scavenger receptors, and enhance cardiomyocyte function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": " In addition, intermedin contributes to metabolic regulation by promoting the beiging of white adipose tissue and increasing energy expenditure, thus offering a potential strategy against obesity and insulin resistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther reports further expand on intermedin’s protective functions in vascular remodeling, prevention of ventilator‐induced lung injury, modulation of macrophage polarization, and attenuation of aneurysm formation through Notch1 signaling inhibition."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "17"}]}, {"type": "t", "text": " Collectively, these studies underscore intermedin’s multifaceted roles in maintaining cardiovascular integrity, modulating inflammatory responses, and regulating metabolic as well as vascular functions.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, while the abstracts provide compelling evidence for intermedin’s broad protective and regulatory functions in cardiovascular, pulmonary, and metabolic systems, they do not address OR4K14. Consequently, based on the present body of literature, no functional information regarding OR4K14 can be inferred from these studies.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jaesook Roh, Chia Lin Chang, Alka Bhalla, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M305332200"}], "href": "https://doi.org/10.1074/jbc.M305332200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14615490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14615490"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "John Patton, Scott Block, Chris Coombs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of functional elements in the murine Gabp alpha/ATP synthase coupling factor 6 bi-directional promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2005.10.009"}], "href": "https://doi.org/10.1016/j.gene.2005.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16309857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16309857"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Feng Dong, Meghan M Taylor, Willis K Samson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Appl Physiol (1985) (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/japplphysiol.01631.2005"}], "href": "https://doi.org/10.1152/japplphysiol.01631.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16763098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16763098"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Heng-Yu Zhang, Wei Jiang, Jian-Ying Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertens Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/hr.2009.120"}], "href": "https://doi.org/10.1038/hr.2009.120"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19680258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19680258"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Uwe Pfeil, Muhammad Aslam, Renate Paddenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Lung Cell Mol Physiol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajplung.90608.2008"}], "href": "https://doi.org/10.1152/ajplung.90608.2008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19684198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19684198"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Toshihiro Ashitate, Tomohiro Osanai, Makoto Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of coupling factor 6 causes cardiac dysfunction under high-salt diet in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hypertens (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/HJH.0b013e32833dfcbe"}], "href": "https://doi.org/10.1097/HJH.0b013e32833dfcbe"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20811295"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20811295"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiao-Yan Dai, Yan Cai, Ding-Ding Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Cell Cardiol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yjmcc.2012.07.006"}], "href": "https://doi.org/10.1016/j.yjmcc.2012.07.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22841663"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22841663"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Christian Körner, Tim Kuchenbuch, Uwe Pfeil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low-dose adrenomedullin-2/intermedin(8-47) reduces pulmonary ischemia/reperfusion injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2014.09.022"}], "href": "https://doi.org/10.1016/j.peptides.2014.09.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25290159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25290159"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hongfei Ren, Hongyu Ren, Xue Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2015.4328"}], "href": "https://doi.org/10.3892/mmr.2015.4328"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26398911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26398911"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ying Lv, Song-Yang Zhang, Xianyi Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adrenomedullin 2 Enhances Beiging in White Adipose Tissue Directly in an Adipocyte-autonomous Manner and Indirectly through Activation of M2 Macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.735563"}], "href": "https://doi.org/10.1074/jbc.M116.735563"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27621315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27621315"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Li-Jun Wang, Fei Xiao, Ling-Miao Kong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin Enlarges the Vascular Lumen by Inducing the Quiescent Endothelial Cell Proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.117.310317"}], "href": "https://doi.org/10.1161/ATVBAHA.117.310317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29242270"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29242270"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Fei Xiao, Denian Wang, Lingmiao Kong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-05062-2"}], "href": "https://doi.org/10.1038/s41467-018-05062-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29980671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29980671"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Qing Zhu, Xian-Qiang Ni, Wei-Wei Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2017.10.011"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2017.10.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29053988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29053988"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Chang-Ding Xue, Yao Chen, Jin-Ling Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2019.170131"}], "href": "https://doi.org/10.1016/j.peptides.2019.170131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31408662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31408662"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xian-Qiang Ni, Ya-Rong Zhang, Li-Xin Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.202436"}], "href": "https://doi.org/10.18632/aging.202436"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33535178"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33535178"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhongxue Feng, Min Li, Aijia Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin (adrenomedullin 2) plays a protective role in sepsis by regulating T- and B-cell proliferation and activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2023.110488"}], "href": "https://doi.org/10.1016/j.intimp.2023.110488"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37352568"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37352568"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ya-Rong Zhang, Shi-Meng Liu, Yao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2023.117342"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2023.117342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37879153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37879153"}]}]}]}
|
| Synonyms | OR14-18, OR14-22 |
| Proteins | OR4KE_HUMAN |
| NCBI Gene ID | 122740 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
OR4K14 has 823 functional associations with biological entities spanning 7 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 41 datasets.
Click the + buttons to view associations for OR4K14 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of OR4K14 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of OR4K14 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of OR4K14 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR4K14 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OR4K14 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of OR4K14 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of OR4K14 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of OR4K14 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing OR4K14 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with OR4K14 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR4K14 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with OR4K14 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by OR4K14 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with OR4K14 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OR4K14 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OR4K14 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of OR4K14 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of OR4K14 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of OR4K14 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving OR4K14 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing OR4K14 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by OR4K14 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by OR4K14 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of OR4K14 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of OR4K14 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for OR4K14 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of OR4K14 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of OR4K14 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving OR4K14 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR4K14 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of OR4K14 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain OR4K14 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of OR4K14 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Reactome Pathways 2014 | pathways involving OR4K14 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving OR4K14 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OR4K14 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of OR4K14 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of OR4K14 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of OR4K14 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of OR4K14 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with OR4K14 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |